Erratum To: Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness

被引:3
|
作者
Vijayalakshmi Kari [ ]
Wael Yassin Mansour [ ]
Sanjay Kumar Raul [ ]
Simon J Baumgart [ ]
Andreas Mund [ ]
Marian Grade [ ]
Hüseyin Sirma [ ]
Ronald Simon [ ]
Hans Will [ ]
Matthias Dobbelstein [ ]
Ekkehard Dikomey [ ]
Steven A Johnsen [ ]
机构
来源
The EMBO Reports | 2018年 / 19卷 / 10期
关键词
D O I
10.15252/embr.201846783
中图分类号
学科分类号
摘要
[graphic not available: see fulltext]
引用
收藏
相关论文
共 50 条
  • [1] Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness
    Kari, Vijayalakshmi
    Mansour, Wael Yassin
    Raul, Sanjay Kumar
    Baumgart, Simon J.
    Mund, Andreas
    Grade, Marian
    Sirma, Hueseyin
    Simon, Ronald
    Will, Hans
    Dobbelstein, Matthias
    Dikomey, Ekkehard
    Johnsen, Steven A.
    EMBO REPORTS, 2016, 17 (11) : 1609 - 1623
  • [2] Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsiveness (vol 17, pg 1609, 2016)
    Kari, Vijayalakshmi
    Mansour, Wael Yassin
    Raul, Sanjay Kumar
    Baumgart, Simon J.
    Mund, Andreas
    Grade, Marian
    Sirma, Huseyin
    Simon, Ronald
    Will, Hans
    Dobbelstein, Matthias
    Dikomey, Ekkehard
    Johnsen, Steven A.
    EMBO REPORTS, 2018, 19 (10)
  • [3] CHD1 as a therapeutic target for prostate cancer.
    Wang, Y. Alan
    Zhao, Di
    Depinho, Ron
    CANCER RESEARCH, 2018, 78 (16) : 79 - 80
  • [4] CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair
    Shenoy, T. R.
    Boysen, G.
    Wang, M. Y.
    Xu, Q. Z.
    Guo, W.
    Koh, F. M.
    Wang, C.
    Zhang, L. Z.
    Wang, Y.
    Gil, V.
    Aziz, S.
    Christova, R.
    Rodrigues, D. N.
    Crespo, M.
    Rescigno, P.
    Tunariu, N.
    Riisnaes, R.
    Zafeiriou, Z.
    Flohr, P.
    Yuan, W.
    Knight, E.
    Swain, A.
    Ramalho-Santos, M.
    Xu, D. Y.
    de Bono, J.
    Wu, H.
    ANNALS OF ONCOLOGY, 2017, 28 (07) : 1495 - 1507
  • [5] CHD1, a multifaceted epigenetic remodeler in prostate cancer
    Li, Haoyan
    Gigi, Loraine
    Zhao, Di
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Monitoring CHD1 During Prostate Cancer Progression
    Rodrigues, Daniel Nava
    Boysen, Gunther
    Mateo, Joaquin
    Christova, Rossitza
    Riisnaes, Ruth
    Crespo, Mateus
    MacDonald, Theresa Y.
    Miranda, Susana A. A.
    Figueiredo, Ines
    Gil, Veronica
    Aziz, Sara
    Mehra, Niven
    Sharp, Adam
    Rescigno, Pasquale
    Mosquera, Juan Miguel
    Barbieri, Christopher E.
    Rubin, Mark
    De Bono, Johann S.
    LABORATORY INVESTIGATION, 2016, 96 : 251A - 251A
  • [7] Monitoring CHD1 During Prostate Cancer Progression
    Rodrigues, Daniel Nava
    Boysen, Gunther
    Mateo, Joaquin
    Christova, Rossitza
    Riisnaes, Ruth
    Crespo, Mateus
    MacDonald, Theresa Y.
    Miranda, Susana A. A.
    Figueiredo, Ines
    Gil, Veronica
    Aziz, Sara
    Mehra, Niven
    Sharp, Adam
    Rescigno, Pasquale
    Mosquera, Juan Miguel
    Barbieri, Christopher E.
    Rubin, Mark
    De Bono, Johann S.
    MODERN PATHOLOGY, 2016, 29 : 251A - 251A
  • [8] Monitoring CHD1 during prostate cancer progression
    Boysen, Gunther
    Rodrigues, Daniel Nava
    Mateo, Joaquin
    Christova, Rossitza
    Riisnaes, Ruth
    Crespo, Mateus
    MacDonald, Theresa
    Miranda, Susana
    Figueiredo, Ines
    Aziz, Veronica Gil Sara
    Sharp, Adam
    Mehra, Niven
    Rescigno, Pasquale
    Mosquera, Juan M.
    Barbieri, Christopher E.
    Rubin, Mark A.
    de Bono, Johann S.
    CANCER RESEARCH, 2016, 76
  • [9] Coordinated roles of CHD1 and SPOP in prostate cancer pathogenesis
    Vasudevan, Divya
    Blattner, Mirjam
    Deonarine, Lesa D.
    Chen, Yu
    Rubin, Mark A.
    Barbieri, Christopher E.
    CANCER RESEARCH, 2016, 76
  • [10] Molecular and clinical implications of CHD1 loss and SPOP mutations in advanced prostate cancer.
    Rescigno, Pasquale
    Boysen, Gunther
    Rodrigues, Daniel Nava
    Seed, George
    Dolling, David
    Riisnaes, Ruth
    Crespo, Mateus
    Bianchini, Diletta
    Sumanasuriya, Semini
    Figueiredo, Ines
    Christova, Rossitza
    Gil, Veronica
    Goodall, Jane
    Sharp, Adam
    Rubin, Mark A.
    Yuan, Wei
    Barbieri, Christopher
    Mateo, Joaquin
    Carreira, Suzanne
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)